Advanced Search

Technical Analysis for MSSTF - Mindset Pharma Inc

Grade Last Price % Change Price Change
B 0.419 -0.62% -0.0026
MSSTF closed down 0.62 percent on Friday, June 18, 2021, on approximately normal volume. It was able to find support at its 50 day moving average.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Up Up
Historical MSSTF trend table...
Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
50 DMA Support Bullish 0.00%
Wide Bands Range Expansion 0.00%
Wide Bands Range Expansion -0.62%
Crossed Above 50 DMA Bullish -1.23%
Wide Bands Range Expansion -1.23%
Gapped Up Strength -1.23%
Fell Below 50 DMA Bearish 10.12%
Narrow Range Bar Range Contraction 10.12%
Inside Day Range Contraction 10.12%
Older End-of-Day Signals for MSSTF ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators Basic chart:

Profile

Mindset Pharma Inc. operates as a neuro-pharmaceutical drug discovery and development platform company. It offers psychedelic compounds for treatment-resistant neurological and psychiatric disorders. The company is headquartered in Toronto, Canada.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Sciences Pharmaceutical Industry Life Sciences Pharmacy Health Care Pharmacology Drug Discovery

Is MSSTF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Jun 14 Mindset and InterVivo Solutions Announce Availability of First Preclinical Psychedelic Benchmark Data from COPE Program
May 5 Mindset Pharma Invited to Present at Canaccord Genuity 41st Annual Growth Conference
Apr 29 Mindset Pharma Announces Positive Preclinical Results of Its Proprietary Next Generation DMT & 5-MeO-DMT Compounds
Apr 28 Mindset Pharma Engages KCSA Strategic Communications to Provide Investor Relations Services
Apr 26 Mindset Pharma Invited to Present at H.C. Wainwright "Psychedelics in Psychiatry and Beyond" Virtual Conference
Apr 19 Mindset Pharma Announces Exercise of Over-Allotment Option for Additional Gross Proceeds of $1.052 Million
Apr 15 Mindset Pharma Announces Closing of $7.5 Million Bought Deal Public Offering
Mar 23 Mindset Pharma and InterVivo Solutions to Jointly Develop Advanced Cooperative Psychedelics Evaluation Platform ("Cope"); Cope Expected to Be World's First in Vivo Psychedelic Benchmark Data Set
Mar 22 IIROC Trade Resumption - MSET
Mar 22 Mindset Pharma Announces Upsize of Bought Deal to $7.5 Million
See more MSSTF news...

Indicators

Indicator Value
52 Week High 1.0718
52 Week Low 0.2959
Average Volume 29,282
200-Day Moving Average 0.0000
50-Day Moving Average 0.3838
20-Day Moving Average 0.3789
10-Day Moving Average 0.4113
Average True Range 0.0414
ADX 14.99
+DI 31.9593
-DI 23.9910
Chandelier Exit (Long, 3 ATRs) 0.3758
Chandelier Exit (Short, 3 ATRs) 0.4201
Upper Bollinger Bands 0.4704
Lower Bollinger Band 0.2874
Percent B (%b) 0.72
BandWidth 48.2977
MACD Line 0.0096
MACD Signal Line 0.0022
MACD Histogram 0.0074
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.4967
Resistance 3 (R3) 0.4916 0.4605 0.4838
Resistance 2 (R2) 0.4605 0.4407 0.4631 0.4794
Resistance 1 (R1) 0.4398 0.4285 0.4502 0.4449 0.4751
Pivot Point 0.4087 0.4087 0.4139 0.4113 0.4087
Support 1 (S1) 0.3880 0.3889 0.3984 0.3931 0.3629
Support 2 (S2) 0.3569 0.3767 0.3595 0.3586
Support 3 (S3) 0.3362 0.3569 0.3543
Support 4 (S4) 0.3413